Sian Sloan-Dennison

A new diagnostic platform may help detect drug-induced liver injury better. How would this work in real-world clinical settings?

The combination of surface-enhanced Raman spectroscopy (SERS) and digital microfluidics (DMF) might be able to improve detection of liver injury biomarkers.

What should students working in clinical research settings keep in mind?

Did you miss Sian Sloan-Dennison’s talk on digital microfluidics and surface-enhanced Raman spectroscopy (SERS) at Spring SciX? If yes, she recaps her talk in this video clip.

In this interview clip, Sian Sloan-Dennison, a postdoctoral research associate at the University of Strathclyde, discusses how a new digital microfluidics surface-enhanced Raman spectroscopy (DMF-SERS) platform be implemented in clinical settings.

Why is determining the function of a surface-enhanced Raman spectroscopy (SERS) assay important? This "Pathways in Spectroscopy" clip offers career advice for researchers in biological and clinical analysis by addressing this question.

What were attendees talking about the most at Spring SciX?

Sian Sloan-Dennison, a postdoctoral research associate at the University of Strathclyde, discusses how young researchers can leverage their time at scientific conferences effectively to land their postdoctoral research opportunity.

Sian Sloan-Dennison, a postdoctoral research associate at the University of Strathclyde, discusses the importance of considering the end-use application of SERS assays and random probes, such as whether they are for early diagnostics or patient use.

Why does integrating a surface-enhanced Raman scattering (SERS) assay with a digital microfluidics (DMF) platform improve sensitivity, reproducibility, and throughput when detecting onset of drug-induced liver injury?

Sian Sloan-Dennison, a postdoctoral research associate at the University of Strathclyde, highlights the key topics that were discussed at Spring SciX.

Our coverage of the Spring SciX Conference includes a profile on the current issues of current clinical diagnostics, including how spectroscopy can improve assessment of drug induced liver injury.